premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly As the market valuations continue to be priced at perfection this is a defensive Top Pick. This low MER ETF tracks US 7-10 year Treasuries -- a safe haven during market down turns. What makes this interesting as well, from an Canadian investor's perspective, is that it is priced in Canadian dollars. This will add another kicker in a market down turn as we expect a flight to the US dollar safety at some point. We would buy this with a $60 stop-loss. Yield 0%
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly MRK is one of the largest pharma companies in the world. It trades at a 13 PE compared to 22 PE for the S&P500. The pandemic has slowed some elective procedures, and that has slowed sales in the latest quarter by about 9%. However, management still opted to raise its 2020 guidance showing confidence that things should improve for the balance of the year. The company also has three drugs moving through various COVID-19 vaccine test trials. It pays a good yield, backed by a 58% payout ratio. We would buy this with an upper target towards $96 as the first objective and use $77 as a stop-loss. Yield 2.95% (Analysts’ price target is $95.94)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly In the search for a pandemic vaccine, JNJ is a potential winner. Leveraging off their proven technology with their Ebola, HIV and other vaccines, the company continues to develop a COVID-19 vaccine that presently shows strong immunity response in 99% of trials. It is also the only option that is testing a single-dose vaccine. Revenues have dipped 10% in the latest quarterly earnings, but that can be attributed to a slow down in elective procedures. It pays a good dividend backed by a 67% payout ratio. We would trade this with a stop-loss at $132. Yield 2.75% (Analysts’ price target is $165.06)
COMMENT
Near-zero interest rates are definitely boosting real estate sales in apartments and houses. Borrowing is so cheap. A private buyer now would be making a bet in certain stable sectors during this pandemic: industrial warehouses, apartments in affordable parts of North America, and single-family rental homes (people can work anymore now). These are all stable and strong. However, retail, office and student houses have questionable stability and are at risk in this Covid environment.
HOLD
A hold. A value name in apartments in Canada and the U.S. He's impressed with how stable their Toronto portfolio is, holding occupancy quite well. MGR is in the US sunbelt and Chicago. MRG is higher-leveraged. He's seeking REITs that are defensive. He doesn't see as much growth here vs. the REITs he already owns. The reason is that MRG is in some weaker U.S. markets.
HOLD
Likes their managers and strategy. They dominate across the Maritimes and have expanded into Ontario, BC, and have a small presence in Calgary. They outperform some apartment REITs, because they lack exposure in urban centres (urban, multi-family REITs have lagged). Killam should stability and growth in the coming year. Problem is that foreign students and movies are not renting in urban areas, and apartments face competition from condo supplies.
BUY ON WEAKNESS
He's bullish on apartments long-term, given supply and demand in many markets. But short-term there's an impact. IIP has a growing presence in Montreal and he likes their overall portfolio, but assets around McGill and Concordia have taken a hit because foreign students can't enter Canada. A blue chip trading cheaply. If you're a longer-term investor, now is the time to invest in this asset class.
STRONG BUY
Collection rate is a good 98% Blue-chip managers and a great portfolio. Definitely own this. It's pulled back to a heavily discounted level to NAV, which means it's cheaper to buy this on the stock market than the private market. Its value is in the $60s, but you can buy it now in the $40s. This REIT is overly discounted now, though it believes in it long term. Also, 15% of their portfolio is in Holland and Ireland, which boasts great supply and demand.
BUY

One of his top picks. It owns apartments in the US sunbelt, especially Texas. He's toured all their assets. Managers own half the company. Trades at a major discount to NAV. A Canadian company that owns US assets, but are not valued like Canadian assets, because investors aren't familiar with those American assets. He looks to the US market for comparable assets to BSR. This is easily worth north of $12 USD.

HOLD
Management has done a great job navigating the virus earlier this year. The sector has taken a hit. Pleased with their occupancy rates, higher than he expected, and in keeping their residents. It's trading at a discount NAV. Hold if you own, but there will be choppiness in months or quarters to come, given Covid headlines. CSH can weather that though. The value of the real estate will still be there, and they are good operators.
PAST TOP PICK

(A Top Pick Jun 25/20, Up 25%) Blackstone did a $300 million preferred investment in Tricon, a great vote of confidence in this company. TCN is a single-family rental home operator, mostly in the U.S. They were a major consolidator, post-2009 recession, exited at the end of 2019, but just re-entered the business. That's why the stock has rallied.

PAST TOP PICK
(A Top Pick Jun 25/20, Up 3%) Still likes it. Focused in Holland, which has a housing shortage and the third-densest country in Europe, and ERE can get 4% rent growth there that it can't in North America. It trades at a discount to NAV. Very defensive.
PAST TOP PICK

(A Top Pick Jun 25/20, Up 15%) They own industrial warehouses, the kind that Amazon and e-commerce uses and booming in this pandemic. It's doing well during the pandemic. Has a great balance sheet with low leverage and in a sector with stable, growing cash flows. They can make accretive acquisitions. Has a valuation gap vs. its peers. Still likes it.

BUY

80% of its assets are retail. He shies away from retail, but Loblaw owns half of those assets, which is stable and boasts high rent collection. The company is in good hands and the dividend is safe. Managers are doing a good job to diversify into apartments and industrial spaces to diversify away from retail.

COMMENT
They intend to spin out their western Canadian retail real assets to become an owner of office and industrial assets in North America. Investors will receive units of this new small-cap REIT, which will be difficult to value. The hope is that the office/industrial REIT will see a re-rating of its value. Spin-outs often don't create value, so he can't evaluate this for another year or longer. Don't own this during the spin, but it may offer value after the spin. They own good industrial assets in Houston, and office buildings in stable markets like Madison, WI, though these markets won't show much growth they have have been stable. The dividend is above 6%.